Alzheimer’s disease is characterized by high levels of BChE activity in the later stages as a compensatory mechanism for downregulating the activity and function of acetylcholinesterase (AChE) [30]. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.